Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dry Eye Institutes of Kentucky and Indiana appears to be a regional specialty eye-care practice focused on the diagnosis and treatment of dry eye disease and related ocular surface disorders. The entity is best understood as a clinical services organization rather than a biotech or pharmaceutical developer, offering patient evaluation, in-office diagnostics, and treatment protocols for chronic dry eye. Publicly available evidence for the exact company name is limited, and the strongest corroborating sources point to related regional dry-eye clinics and broader Dry Eye Institutes branding rather than a clearly documented standalone corporate profile under this exact name. Based on the available information, it operates in commercial healthcare services with a focus on ophthalmology/optometry care in Kentucky and Indiana. It does not appear to have a therapeutic drug pipeline or proprietary clinical-stage assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dry Eye Institutes of Kentucky and Indiana.